AI-generated summary
The authors studied photobiomodulation at 685 nm in streptozotocin-induced diabetic rats with Staphylococcus aureus-infected surgical wounds. They report lower bacterial counts, shorter wounds at weeks 2 and 3, and higher breaking strength in treated animals compared with controls. The study used rats, so the findings may not apply directly to humans.
- Participants
- 30
- Who or what was studied
- Thirty streptozotocin-induced diabetic rats with S. aureus-infected dorsal surgical wounds
- Wavelengths
- 685 nm
- Limits stated in the abstract
- The study was conducted in diabetic rats, not humans, and the abstract does not report statistical details beyond significance levels.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on scielo.br.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 685 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Control group, Wound healing. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.